CME Group Inc. Files 8-K on Shareholder Vote Matters

Ticker: CME · Form: 8-K · Filed: 2024-05-13T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, shareholder-vote

Related Tickers: CME

TL;DR

CME Group is holding a shareholder vote; details to follow.

AI Summary

On May 9, 2024, CME Group Inc. filed an 8-K report detailing a submission of matters to a vote of security holders. The filing, submitted on May 13, 2024, pertains to a shareholder vote, the specifics of which are not detailed in this excerpt but are a standard corporate governance procedure.

Why It Matters

This filing indicates a formal process where CME Group's security holders are being asked to vote on certain corporate matters, a key aspect of corporate governance.

Risk Assessment

Risk Level: low — The filing is a routine procedural disclosure regarding a shareholder vote, not indicating any immediate financial or operational risks.

Key Players & Entities

CME Group Inc. (company) — Registrant
20 South Wacker Drive (location) — Principal Executive Offices
Chicago, Illinois 60606 (location) — Principal Executive Offices
May 9, 2024 (date) — Date of earliest event reported
May 13, 2024 (date) — Date of report

FAQ

What specific matters were submitted for a vote of security holders by CME Group Inc.?

The provided excerpt of the 8-K filing does not specify the exact matters submitted for a vote of security holders; it only states that such matters were submitted.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on May 9, 2024.

What is the principal executive office address for CME Group Inc.?

The principal executive office address for CME Group Inc. is 20 South Wacker Drive, Chicago, Illinois 60606.

What is CME Group Inc.'s IRS Employer Identification Number?

CME Group Inc.'s IRS Employer Identification Number is 36-4459170.

Under which section of the Securities Exchange Act of 1934 is this Current Report filed?

This Current Report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

From the Filing

0001193125-24-136767.txt : 20240513 0001193125-24-136767.hdr.sgml : 20240513 20240513084832 ACCESSION NUMBER: 0001193125-24-136767 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240509 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20240513 DATE AS OF CHANGE: 20240513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CME GROUP INC. CENTRAL INDEX KEY: 0001156375 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES [6200] ORGANIZATION NAME: 02 Finance IRS NUMBER: 364459170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31553 FILM NUMBER: 24937065 BUSINESS ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 3129301000 MAIL ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 FORMER COMPANY: FORMER CONFORMED NAME: CHICAGO MERCANTILE EXCHANGE HOLDINGS INC DATE OF NAME CHANGE: 20010802 8-K 1 d803237d8k.htm 8-K 8-K false 0001156375 0001156375 2024-05-09 2024-05-09     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     FORM 8-K     CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) May 13, 2024 ( May 9, 2024 )     CME GROUP INC. (Exact Name of Registrant as Specified in Charter)       Delaware   001-31553   36-4459170 (State or Other Jurisdiction of Incorporation)   (Commission File No.)   (IRS Employer Identification No.) 20 South Wacker Drive Chicago , Illinois 60606 (Address of Principal Executive Offices) (Zip Code) Registrant’s telephone number, including area code: (312) 930-1000 N/A (Former Name or Former Address, if Changed Since Last Report)     Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol   Name of each exchange on which registered Class A Common Stock   CME   Nasdaq Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 5.07. Submission of Matters to a Vote of Security Holders. CME Group Inc. (the “Company”) held its 2024 Annual Meeting of Shareholders on May 9, 2024 (the “Annual Meeting”). At the close of business on March 11, 2024, the record date of the Annual Meeting, the Company had 360,025,217 shares of Class A and Class B common stock issued and outstanding. The following shares were present at the Annual Meeting, either in person at the virtual shareholder meeting or by proxy.   Class(es) of Common Stock    Aggregate No. of Shares      % of&